1. Raban V. Jeger, Simon Eccleshall, Wan Azman Wan Ahmad, Junbo Ge, Tudor C. Poerner, Eun-Seok Shin, Fernando Alfonso, Azeem Latib, Paul J. Ong, Tuomas T. Rissanen, Jorge Saucedo, Bruno Scheller, Franz X. Kleber and for the International DCB Consensus Group Drug-Coated Balloons for Coronary Artery Disease. Third Report of the International DCB Consensus Group. JACC Cardiovasc Interv. 2020 May (In press)
  2. Ho HH, Sinaga DA, Arshad MKM, Kasim S, Lee JH, Khoo DZL, Loh KK, Jafary FH, Ong PJL, Lo SSS. 12-Month clinical outcomes of amphilimus drug eluting stents in an all-comers South-East Asian registry. Int J Cardiol Heart Vasc. 2020 Jan 23;26:100469.
  3. Takahashi K, SerruysPW, Chichareon P, Chang CC, Tomaniak M, Modolo R, Kogame N, Magro M, Chowdhary S, Eitel I, Zweiker R, Ong P, Ottesen MM, Tijssen JGP, Wykrzykowska JJ, de Winter RJ, Garg S, Stoll HP, Hamm C, Steg PG, Onuma Y, Valgimigli M, Vranckx P, Carrie D, Windecker S. Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI. J Am Coll Cardiol. 2019 Oct 22;74(16):2015-2027
  4. Frigoli E, Smits P, Vranckx P, Ozaki Y, Tijssen J, Jüni P, Morice MC, Onuma Y, Windecker S, Frenk A, Spaulding C, Chevalier B, Barbato E, Tonino P, Hildick-Smith D, Roffi M, Kornowski R, Schultz C, Lesiak M, Iñiguez A, Colombo A, Alasnag M, Mullasari A, James S, Stankovic G, Ong PJL, Rodriguez AE, Mahfoud F, Bartunek J, Moschovitis A, Laanmets P, Leonardi S, Heg D, Sunnåker M, Valgimigli M. Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study. Am Heart J. 2018 Nov 22;209:97-105.
  5. HH Ho and Ong PJL. Basket-Small 2: advancing DCB beyond in-stent restenosis. 2018 Sep 8;392(10150):802-804
  6. Khoo DZL, Lee JH, Watson TJ and Ong PJL. The Solitaire device – on the cards for retrieval of recalcitrant thrombus in acute coronary syndrome. 2019 Apr 5;14(18)
  7. Lee DJH, Loh JKK, Jafary FH, Ho HH, Watson T, Stoll HP, Ong PJL. Polymer-free biolimus-A9-coated stent for primary percutaneous coronary intervention. Herz. 2018 Apr 17 (Epub ahead of print)
  8. Tan CK, Tin ZL, Arshad MKM, Loh JKK, Jafary FH, Ho HH, Ong PJL, Watson T.Treatment with 48-mm everolimus-eluting stents : Procedural safety and 12-month patient outcome. Herz. 2018 Jan 16 (Epub ahead of print)
  9. Jensen CJ, Naber CK, Urban P, Ong PJ, Valdes-Chavarri M, Abizaid AA, Pocock SJ, Fabbiocchi F, Dubois C, Copt S, Stoll HP, Morice MC. Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy. EuroIntervention. 2018 Mar 20;13(16):1946-1949
  10. Sim WJ, Ang AS, Tan MC, Xiang WW, Foo D, Loh KK, Jafary FH, Watson TJ, Ong PJL, Ho HH. Causes of delay in door-to-balloon time in south-east Asian patients undergoing primary percutaneous coronary intervention. PLoS One. 2017 Sep 21;12(9):e0185186
  11. Smits PC, Abdel-Wahab M, Neumann FJ, Boxma-de Klerk BM, Lunde K, Schotborgh CE, Piroth Z, Horak D, Wlodarczak A, Ong PJ, Hambrecht R, Angerås O, Richardt G, Omerovic E; Compare-Acute Investigators. Fractional Flow Reserve-Guided Multivessel Angioplasty In Myocardial Infarction. N Engl J Med. 2017 Mar 30;376(13):1234-1244
  12. Garot P, Morice MC, Tresukosol D, Pocock SJ, Meredith IT, Abizaid A, Carrié D, Naber C, Iñiguez A, Talwar S, Menown IBA, Christiansen EH, Gregson J, Copt S, Hovasse T, Lurz P, Maillard L, Krackhardt F, Ong P, Byrne J, Redwood S, Windhövel U, Greene S, Stoll HP, Urban P; LEADERS FREE Investigators. 2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents. J Am Coll Cardiol. 2017 Jan 17;69(2):162-171
  13. Ong PJ, Wijns WC. Save your blushes and stop routine thrombus aspiration during primary PCI. Eur Heart J. 2016 Jun 21;37(24):1899-901
  14. Naber CK, Urban P, Ong PJ, Valdes-Chavarri M, Abizaid AA, Pocock SJ, Fabbiocchi F, Dubois C, Copt S, Greene S, Morice MC; LEADERS FREE Investigators. Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-study. Eur Heart J. 2017 Apr 1;38(13):961-969.
  15. Ong PJ, Kubo T, Watson TJ, Seah AS, Wong PE, Akasaka T. Angiographic, optical coherence tomography and histology findings from combination of a drug-coated balloon with an everolimus-eluting stent in a porcine model. Int J Cardiol. 2016 Nov 15;223:665-668
  16. Scheller B, Ong PJ, Kleber F. Drug-Coated Balloon Treatment as Default Strategy for DES-ISR. J Am Coll Cardiol. 2016 Jan 26;67(3):346-7
  17. Leaders Free Investigators. Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk. N Engl J Med. 2015 Nov 19;373(21):2038-47
  18. Sinaga D, Ho HH, Zeymer U, Waliszewski M, Jafary FJ, Ooi YW, Loh JKK, Tan JKB and Ong PJ. Drug coated balloon angioplasty in elderly patients with small vessel coronary disease. Ther Adv Cardiovasc Dis. 2015 Dec;9(6):389-96.
  19. Ong PJ, Jafary FH and Ho HH. Drug-coated balloon for coronary indications: too little, too late? J Interv Cardiol. 2015 28(2):218-9
  20. Ho HH, Tan J, Ooi YW, Loh KK, Aung TH, Yin NT, Sinaga DA, Jafary FH and Ong PJ. Preliminary experience with drug-coated balloon angioplasty in primary percutaneous coronary intervention. World J Cardiol. 2015 Jun 26;7(6):311-4.
  21. Pua U, Tan CH, Ho HH, Tan JK, Ong PJ. Revisiting renovascular imaging for renal sympathetic denervation: current techniques and applications. Euro Radiol 2015 25(2):444-53
  22. GSR Investigators. First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension. 2015 Apr;65(4):766-74.
  23. Tan A, Hau W, Ho HH, Ghaem Maralani H, Loo G, Khoo SM, Tai BC, Richards AM, Ong P, Lee CH. OSA and Coronary Plaque Characteristics. 2014 Feb;145(2):322-30.
  24. Ho HH, Ong HA, Arasaratnam P, Ooi YW, Tan J, Loh KK, Foo D, Haider F, Ong PJ. Predictors of in-hospital mortality in patients with acute myocardial infarction complicated by cardiogenic shock in the contemporary era of primary percutaneous coronary intervention. Int J Cardiol. Heart Vessels 2014 (3):88-89
  25. Ching ME, Ong PJ, Ho HH. Subclavian steal syndrome in a post-coronary artery bypass patient. Asian Cardiovasc Thorac Ann. 2015. 23(6):738-9
  26. PJ Ong, U Zeymer; M Waliszewski, J Tan, HH Ho. Differences in Clinical and Angiographic Profiles between Asian and Western Patients with Coronary Artery Disease : Insights from the Prospective “Real World” Paclitaxel-Coated Balloon Registry. Int J Cardiol 2014; 175(1):199-200
  27. Ho HH, Ooi YW, Loh KK, Tan J; Aung TH; Jafary FH, Ong PJ. Clinical Efficacy and Safety of SeQuent Please Paclitaxel-Eluting Balloon in a Real-World Single-Center Registry of South-East Asian Patients. Int J Cardiol. Heart Vessels 2013 (1):37-41
  28. Ho HH, Ching ME, Ong PJ, Ooi YW. Subacute bioresorbable vascular scaffold thrombosis: a report of 2 cases. Heart Vessels. 2015 Jul;30(4):545-8.
  29. Zeymer U, Waliszewski M, Spiecker M, Gastmann O, Faurie B, Ferrari M, Alidoosti M, Palmieri C, Tay NH, Ong PJ, Dietz U. Prospective ‘real world’ registry for the use of the ‘PCB only’ strategy in small vessel de novo lesions. 2014 Feb;100(4):311-6
  30. Khoo DZ, Lee E, Ong PJ, Ho HH. Optical Coherence Tomographic Imaging in a Patient with Wegener’s Granulomatosis Presenting with Acute Myocardial. J Rheumatol. 2014 May;41(5):971-2.
  31. Tan A, Hau W, Ho HH, Maralani HG, Loo G, Khoo SM, Tai BC, Richards AM, Ong P, Lee CH. Obstructive Sleep Apnea and Coronary Plaque Characteristics. 2013 Oct:10.1378.13-1163.
  32. Loo G, Shen L, Ho HH, Richards AM, Ong P, Lee CH. Relationship between CHA65DS2 score and obstructive sleep apnea (CHA65DS2 and OSA). Int J Cardiol. 2013 Oct;168(5):5037-9:10.1016
  33. Ong PJ, Jafary FH, Ho HH. First-In-Man”Use of Bioresorbable Vascular Scaffold in Saphenous Vein Graft. EuroIntervention. 2013 May 20;9(1):165
  34. Ho HH, Aung TH, Wong CP, Huang W, Francis PJ, Foo D,Ong PJ, Yeo D. Successful treatment of a patient with chronic thromboembolic pulmonary hypertension with rivaroxaban. Int J Cardiol. 2013 Apr 13. pii: S0167-5273
  35. Ong PJ, Khurana R, Wong PE, Lukito AA, HH Ho. Preliminary Experience With A Novel Titan-V Stent For Ostial Coronary Lesions In An Experimental Animal Model. Int J Cardiol. 2013 Jul 1;166(3):e53-5.
  36. Ong PJ, Foo D, Ho HH. Successful treatment of resistant hypertension with percutaneous renal denervation therapy. 2012 Dec;98(23):1754-5
  37. Arasaratnam P, Ho HH, Low W, Wilkinson N, Foo D, Ong PJ. Radiation Dose Surveillance using a Novel Automated, Remote- Site Dose Monitoring Tool in Cardiac Catheterization Laboratory: A Feasibility Study. Int J Cardiol. 2012 Nov; 17(12)01468-4
  38. Ho HH, Jafary FH, Loh KK, Tan JKB, Ooi YW, Ong PJ. Deliverability of Integrity Coronary Stents in Severely Tortuous Coronary Arteries: A Preliminary Experience. Invasive Cardiol. 2012 Dec;24(12):650-4
  39. Ong ME, Wong AS, Seet CM, Teo SG, Lim BL, Ong PJ, Lai SM, Ong SH, Lee FC, Chan KP, Anantharaman V, Chua TS, Pek PP, Li H. Nationwide Improvement of Door-to-Balloon Times in Patients With Acute ST-Segment Elevation Myocardial Infarction Requiring Primary Percutaneous Coronary Intervention With Out-of-Hospital 12-Lead ECG Recording and Transmission. Ann Emerg Med. 2013 Mar;61(3):339-47
  40. Wong CP, Ho HH, Jafary FH, Ong PJ. Rheolytic thrombectomy in patients with massive pulmonary embolism: a report of two cases and review of literature. Acute Card Care.2012 Sep;14(3):91-3.
  41. Ho HH, Foo D, Ong PJ. Successful Pre-operative Treatment of A Patient with Resistant Hypertension with Percutaneous Renal Denervation Therapy before Bariatric Surgery. J Clin Hypertens 2012 August;14(8):569-70
  42. Wong CP, Loh SY, Loh KK, Ong PJ, Foo D, Ho HH. Acute Myocardial Infarction: Clinical features and outcomes in young adults in Singapore. World J Cardiol. 2012 Jun 26;4(6):206-10
  43. Ho HH, Jafary FH, Ong PJ. Radial artery spasm during transradial cardiac catheterization and percutaneous coronary intervention: incidence, predisposing factors, prevention, and management. Cardiovasc Revasc Med 2012 May-Jun;13(3):193-5
  44. Soon D, Ho HH, Loh KK, Ooi YW, Foo D, Jafary FH, Ong PJ. Clinical Outcomes of Intracoronary Eptifibatide Bolus-only versus Intracoronary Bolus and Intravenous Infusion of Eptifibatide in Primary Percutaneous Coronary Intervention. Acute Card Care 2012 January 24. 2012 Mar;14(1):42-4
  45. Ho HH, Wong CP, Hau WK, Loh JK, Ong PJ. Intravascular ultrasound virtual histology imaging in acute ST-elevation myocardial infarction: A useful clinical tool during primary percutaneous coronary intervention. Acute Card Care 2011 December 1;13(4):245-7.
  46. Ong PJ, Ho HH, Jafary FH, Loh JKK, Ooi YW, Wong CP et al. Good visibility of TITAN-2 coronary stents demonstrable on cardiac computer tomographic angiography: a report of 2 cases. Acute Card Care 2011 September 1;13(3):202-4.
  47. Ho HH, Loh KK, Ooi YW, Ong PJ. Successful percutaneous coronary intervention of 2 cases of complex coronary lesions facilitated by use of 0.010-inch guidewire and compatible balloon catheters. J Interv Cardiol 2011 August 1;24(4):315-9.
  48. Ho HH, Foo D, Ong PJ. Intravascular ultrasound-virtual histology imaging in acute myocardial infarction. Postgrad Med J 2011 May 1;87(1027):384-5.
  49. Shaukat A, Al-Bustami M, Ong PJ. Chronic total occlusion–use of a 5 French guiding catheter in a 6 French guiding catheter. J Invasive Cardiol 2008 June 1;20(6):317-8.
  50. Saraf S, Ong PJ, Gorog DA. ClearWay RX – Rapid exchange therapeutic perfusion catheter. EuroIntervention 2008 March 1;3(5):639-42.
  51. Mirza FS, Ong P, Collins P, Okamura K, Gerhard-Herman M, Williams GH et al. Effects of estradiol and the angiotensin II receptor blocker irbesartan on vascular function in postmenopausal women. Menopause 2008 January 1;15(1):44-50.
  52. Chong CF, Ong PJ, Moat N, Collins P. Effects of hydrostatic distention on in vitro vasoreactivity of radial artery conduits. J Thorac Cardiovasc Surg 2004 October 1;128(4):609-14.
  53. Al-Bustami M, Ong PJ. Percutaneous Coronary Intervention in a long lesion in small vessles. EuroIntervention 2007 August 1;3(2)
  54. Chong WC, Ong PJ, Hayward CS, Collins P, Moat NE. Effects of radial artery harvesting on forearm function and blood flow. Ann Thorac Surg 2003 April 1;75(4):1171-4.
  55. Sorensen MB, Collins P, Ong PJ, Webb CM, Hayward CS, Asbury EA et al. Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance. Circulation 2002 September 24;106(13):1646-51.
  56. Ong PJ, Webb CM, Sorensen MB, Hayward CS, Collins P. A comparison of brachial artery reactivity measured by external and intravascular ultrasound. Ultrasound Med Biol 2002 July 1;28(7):911-6.
  57. Ong PJ, Linardou H, Graham HA, Savage P, Hayward CS, Coombes RC et al. Tamoxifen is not detrimental to endothelial function in postmenopausal women with breast cancer. Am Heart J 2001 October 1;142(4):E6.
  58. Chong WC, Ong PJ, Hayward C, Moat N, Collins P. Effects of storage solutions on in vitro vasoreactivity of radial artery conduits. J Thorac Cardiovasc Surg 2001 September 1;122(3):470-5.
  59. Ong PJ, Patrizi G, Chong WC, Webb CM, Hayward CS, Collins P. Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease. Am J Cardiol 2000 January 15;85(2):269-72.
  60. Ong PJ, Dean TS, Hayward CS, la Monica PL, Sanders TA, Collins P. Effect of fat and carbohydrate consumption on endothelial function. Lancet 1999 December 18;354(9196):2134.
  61. Ong PJ, Sorensen MB, Hayward CS, Webb CM, Collins P. Hormone replacement therapy for secondary prevention of coronary heart disease. JAMA 1999 March 3;281(9):794-5.
  62. Ong PJ, Burton GJ. Thinning of the placental villous membrane during maintenance in hypoxic organ culture: structural adaptation or syncytial degeneration? Eur J Obstet Gynecol Reprod Biol 1991 April 16;39(2):103-10.
Seraphinite AcceleratorOptimized by Seraphinite Accelerator
Turns on site high speed to be attractive for people and search engines.